Using NAL-NL3 in clinical practice: a modular NAL fitting system for real-world listening needs.

IF 2 3区医学 Q2 AUDIOLOGY & SPEECH-LANGUAGE PATHOLOGY

International Journal of Audiology Pub Date : 2026-06-27 DOI:10.1080/14992027.2026.2680131

Matthew Croteau, Catherine Kwok

{"title":"Using NAL-NL3 in clinical practice: a modular NAL fitting system for real-world listening needs.","authors":"Matthew Croteau, Catherine Kwok","doi":"10.1080/14992027.2026.2680131","DOIUrl":null,"url":null,"abstract":"Objective: To provide hearing care professionals (HCPs) with an overview of the NAL-NL3 fitting system and to guide its use in clinical practice. The aim is to translate the research underpinning NAL-NL3 into practical guidance.Design: This Clinical Note outlines the rationale and clinical application of the NAL-NL3 fitting system, which at launch comprises the NAL-NL3 Prescription, the Comfort in Noise (CIN) Module, and the Minimal Hearing Loss (MHL) Module.Results: The NAL-NL3 fitting system was developed through laboratory and field testing and feedback from hearing care professionals. The NAL-NL3 Prescription provides amplification that aligns more closely with clinical needs, improving first-fit satisfaction and clinical efficiency for a wider range of cases. The Comfort in Noise Module offers a comfort-focused amplification profile adapted for noisy environments, improving comfort and reducing listening fatigue while maintaining speech intelligibility. The Minimal Hearing Loss Module extends hearing aid fitting to adults with normal or near-normal hearing thresholds who experience hearing difficulties, providing safe access to hearing aid technologies.Conclusions: NAL-NL3 is the next generation of NAL's evidence-based philosophy towards prescribing hearing aid amplification. Its modular design enables hearing care professionals to better personalise fittings to patients' communication needs, supporting patient-centred care.","PeriodicalId":13759,"journal":{"name":"International Journal of Audiology","volume":" ","pages":"1-13"},"PeriodicalIF":2.0000,"publicationDate":"2026-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Audiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14992027.2026.2680131","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"AUDIOLOGY & SPEECH-LANGUAGE PATHOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To provide hearing care professionals (HCPs) with an overview of the NAL-NL3 fitting system and to guide its use in clinical practice. The aim is to translate the research underpinning NAL-NL3 into practical guidance.

Design: This Clinical Note outlines the rationale and clinical application of the NAL-NL3 fitting system, which at launch comprises the NAL-NL3 Prescription, the Comfort in Noise (CIN) Module, and the Minimal Hearing Loss (MHL) Module.

Results: The NAL-NL3 fitting system was developed through laboratory and field testing and feedback from hearing care professionals. The NAL-NL3 Prescription provides amplification that aligns more closely with clinical needs, improving first-fit satisfaction and clinical efficiency for a wider range of cases. The Comfort in Noise Module offers a comfort-focused amplification profile adapted for noisy environments, improving comfort and reducing listening fatigue while maintaining speech intelligibility. The Minimal Hearing Loss Module extends hearing aid fitting to adults with normal or near-normal hearing thresholds who experience hearing difficulties, providing safe access to hearing aid technologies.

Conclusions: NAL-NL3 is the next generation of NAL's evidence-based philosophy towards prescribing hearing aid amplification. Its modular design enables hearing care professionals to better personalise fittings to patients' communication needs, supporting patient-centred care.

查看原文本刊更多论文

在临床实践中使用NAL- nl3：一个模块化的NAL装配系统，用于现实世界的听力需求。

目的：为听力保健专业人员（HCPs）提供NAL-NL3配体系统的概述，并指导其在临床中的应用。目的是将支持NAL-NL3的研究转化为实际指导。设计：本临床说明概述了NAL-NL3配体系统的基本原理和临床应用，该系统在推出时包括NAL-NL3处方、噪音舒适（CIN）模块和最小听力损失（MHL）模块。结果：NAL-NL3助听器系统是通过实验室和现场测试以及听力保健专业人员的反馈而开发的。NAL-NL3处方提供了更紧密地符合临床需求的放大，提高了更大范围病例的首次匹配满意度和临床效率。舒适噪音模块提供了适合于嘈杂环境的以舒适为重点的放大配置文件，在保持语音清晰度的同时提高舒适度，减少听力疲劳。最小听力损失模块将助听器安装扩展到听力障碍正常或接近正常听力阈值的成年人，提供安全的助听器技术。结论：NAL- nl3是NAL在处方助听器放大方面的下一代循证哲学。它的模块化设计使听力保健专业人员能够更好地根据患者的沟通需求定制配件，支持以患者为中心的护理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Audiology 医学-耳鼻喉科学

CiteScore

4.90

自引率

14.80%

发文量

133

审稿时长

4-8 weeks

期刊介绍： International Journal of Audiology is committed to furthering development of a scientifically robust evidence base for audiology. The journal is published by the British Society of Audiology, the International Society of Audiology and the Nordic Audiological Society.